There’s definitely understandable frustration an

There’s definitely understandable frustration and dissatisfaction with the performance of the stock. Excellagen funding sounded imminent. I hope we see an 8k there. The IND sounds more like early July unless I’m assessing that wrong, with a fast Phase I because they don’t need a lot of subjects. The Quarterly report is in a week or two. Excellagen approval in Malaysia was said to be by now, so let’s see if there’s an update there. Sanjay talked of positive items in Arizona, learning of success would be great. There’s much happening, but it doesn’t feel like it as wee look in from the outside especially with no positive reaction from the market. We need a strong catalyst.